Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Ann Surg Oncol Early Release, published online ahead of print Mar 15 2004
Annals of Surgical Oncology, 10.1245/ASO.2004.09.012
© 2004 Society of Surgical Oncology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stippel, D. L.
Right arrow Articles by Beckurts, K. T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stippel, D. L.
Right arrow Articles by Beckurts, K. T. E.
Related Collections
Right arrow Ablative therapies

Original Articles

Variability of Size and Shape of Necrosis Induced by Radiofrequency Ablation in Human Livers: A Volumetric Evaluation

Dirk L. Stippel, MD, Hans G. Brochhagen, MD, Mahesh Arenja, Jens Hunkemöller, Arnulf H. Hölscher, MD, FACS, FRCS, K. Tobias E. Beckurts, MD

From the Department of Visceral and Vascular Surgery (DLS, MA, JH, AHH, KTEB) and Institute of Radiology (HGB), University Of Cologne, Cologne, Germany.

Address correspondence and reprint requests to: Dirk L. Stippel, MD, Department of Visceral and Vascular Surgery, University of Cologne, Joseph-Stelzmann-Stra{beta}e 9, 50931 Cologne, Germany; Fax: 49-221-4786258.


   Abstract

Background: Definite size and shape of radiofrequency-induced ablations (RFAs) cannot be evaluated intraoperatively. Instead, surgeons choose a radiofrequency device that is supposed to cause a necrosis of a determined size greater than the malignant lesion. The aim of this study was to measure the variability of the induced necroses postoperatively and to define a reproducible ablation volume in human liver.

Methods: In 24 patients, 34 RFA procedures were performed with single applications of the device. The deployment was 3 cm (n = 16), 4 cm (n = 5), or 5 cm (n = 13). The induced necroses were analyzed by volumetric reconstructions of computed tomography (CT) scans. Measured volumes were compared with the expected volumes. Furthermore, the shape of the necrosis was classified according to an index of the diameters.

Results: The measured volumes of postoperative necroses were 14 ± 8 cm3 (deployment, 3 cm), 24 ± 12 cm3 (4 cm), and 45 ± 42 cm3 (5 cm). The diameter of a sphere fitted into the necroses reached 2.9 ± .5 cm (3 cm), 3.5 ± .7 cm (4 cm), and 4.1 ± 1.1 cm (5 cm), at P < .02, significantly smaller than the deployment. The classification of shapes yielded a spherical shape (n = 14), a teardrop shape (n = 13), or an irregular shape (n = 7). The energy consumption was 2.1 ± 1.5 kJ/cm3 (3 cm), 2.6 ± .5 kJ/cm3 (4 cm), or 3.5 ± 2.0 kJ/cm3 (5 cm).

Conclusions: The diameter of RFA-induced liver necrosis is significantly smaller than expected from needle deployment, especially with full-needle deployment. The shape of the lesion differs in more than half of the cases from the anticipated spherical pattern. The upper limit for reproducible necrosis induction is a tumor diameter of 3.4 cm.

Key Words: Computed tomography, Liver, Radiofrequency ablation, Shape, Volume




This article has been cited by other articles:


Home page
Arch SurgHome page
F. F. Amersi, A. McElrath-Garza, A. Ahmad, T. Zogakis, D. P. Allegra, R. Krasne, and A. J. Bilchik
Long-term Survival After Radiofrequency Ablation of Complex Unresectable Liver Tumors
Arch Surg, June 1, 2006; 141(6): 581 - 588.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. A. Ahmad
Editorial: Limitations of Radiofrequency Ablation in Treating Liver Metastases: A Lesson in Geometry
Ann. Surg. Oncol., April 1, 2004; 11(4): 358 - 359.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society of Surgical Oncology.